159 related articles for article (PubMed ID: 13350341)
1. Hypoglycemic action of orinase, effect on output of glucose by liver.
ANDERSON GE; PERFETTO AJ; TERMINE CM; MONACO RR
Proc Soc Exp Biol Med; 1956 Jun; 92(2):340-5. PubMed ID: 13350341
[No Abstract] [Full Text] [Related]
2. Studies on the mechanism of action of orinase (tolbutamide).
VAUGHAN M
Diabetes; 1957; 6(1):16-8; discussion, 19-20. PubMed ID: 13397412
[No Abstract] [Full Text] [Related]
3. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues.
BRITTON B; GRABOWSKI R; WICK AN
Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041
[No Abstract] [Full Text] [Related]
4. Observations on the action of tolbutamide.
ANDERSON GE; MONACO RN; PERFETTO AJ; TERMINE CM
Diabetes; 1957; 6(1):34-40; discussion, 43-5. PubMed ID: 13397419
[No Abstract] [Full Text] [Related]
5. Role of the adrenal in response of rats to orinase.
DULIN WE; MORLEY EH; NEZAMIS JE
Proc Soc Exp Biol Med; 1956 Oct; 93(1):133-6. PubMed ID: 13370600
[No Abstract] [Full Text] [Related]
6. Antibacterial properties of orinase in infected mice.
LEWIS C
Proc Soc Exp Biol Med; 1957 Apr; 94(4):772-4. PubMed ID: 13431950
[No Abstract] [Full Text] [Related]
7. Effect of tolbutamide (orinase) on plasma non-esterified fatty acids.
BIERMAN EL; ROBERTS TN; DOLE VP
Proc Soc Exp Biol Med; 1957 Jul; 95(3):437-9. PubMed ID: 13453461
[No Abstract] [Full Text] [Related]
8. Hypoglycemic actions of tolbutamide and carbutamide.
TUCKER BW; WILLIAMS RH
Metabolism; 1956 Nov; 5(6 Part 2):801-6. PubMed ID: 13378049
[No Abstract] [Full Text] [Related]
9. Acute effects of orinase on peripheral glucose utilization.
GILBERTSEN AS; GOETZ FC; JOSEPHSON V
Metabolism; 1956 Nov; 5(6 Part 2):788-800. PubMed ID: 13378048
[No Abstract] [Full Text] [Related]
10. Clinical use of tolbutamide (orinase) in office and home care of diabetics.
BRENEMAN JC
J Am Med Assoc; 1957 Jun; 164(6):627-33. PubMed ID: 13428534
[No Abstract] [Full Text] [Related]
11. [Peripheral effect of new urea derivatives with hypoglycemic action].
CANAL N; GARATTINI S; TESSARI L
Boll Soc Ital Biol Sper; 1956 Jun; 32(6):491-4. PubMed ID: 13374139
[No Abstract] [Full Text] [Related]
12. Action of butyltolylsulfonylurea on liver glycogenolysis.
TYBERGHEIN JM; HALSEY YD; WILLIAMS RH
Proc Soc Exp Biol Med; 1956 Jun; 92(2):322-4. PubMed ID: 13350335
[No Abstract] [Full Text] [Related]
13. Some observations on the mode of action of orinase.
ARAI Y; ELRICK H; HLAD C; PRATT E; PURNELL R
Metabolism; 1956 Nov; 5(6 Part 2):778-87. PubMed ID: 13378047
[No Abstract] [Full Text] [Related]
14. Studies on the actions of oral hypoglycemic compounds.
COX RW; WILLIAMS RH
Diabetes; 1957; 6(3):270-3. PubMed ID: 13427634
[No Abstract] [Full Text] [Related]
15. Some effects of orinase in the rat.
LANG S; SHERRY S
Metabolism; 1956 Nov; 5(6 Part 2):733-8. PubMed ID: 13378040
[No Abstract] [Full Text] [Related]
16. Physiologic actions of orinase and their relationship to the types of diabetes in man.
KARK RM; MOORHOUSE JA
Metabolism; 1956 Nov; 5(6 Part 2):847-63. PubMed ID: 13378054
[No Abstract] [Full Text] [Related]
17. The use of orinase in diabetes.
BEASER SB
Metabolism; 1956 Nov; 5(6 Part 2):933-9. PubMed ID: 13378062
[No Abstract] [Full Text] [Related]
18. Metabolic effects of orinase in diabetes including two cases complicated by other endocrinopathies; preliminary report.
DIRAIMONDO VC; FORSHAM PH; MORTIMORE GE
Metabolism; 1956 Nov; 5(6 Part 2):840-6. PubMed ID: 13378053
[No Abstract] [Full Text] [Related]
19. Hypoglycemic sulfonylureas in various types of experimental diabetes.
BUSE JF; GORDON MF; LUKENS FD
Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410
[No Abstract] [Full Text] [Related]
20. [The effect of a new antidiabetic sulfonamide on the intestinal flora].
MEHNERT H
Klin Wochenschr; 1956 Jun; 34(23-24):644-5. PubMed ID: 13347031
[No Abstract] [Full Text] [Related]
[Next] [New Search]
